Invited Comments to the National Research Council Committee on "Future Biotechnology Products and Opportunities to Enhance the Capabilities of the Biotechnology Regulatory System." By Doug Gurian-Sherman, Ph.D.
CFS Comments on the Food and Drug Administration’s Draft Environmental Assessment and Preliminary Finding of No Significant Impact for the Release of Genetically Engineered Mosquitoes as an Investigational New Animal Drug (Docket No. FDA-2014-N-2235)
Letter from CFS, American Bird Conservancy and allies requesting improvements to the Environmental Protection Agency (EPA) incident reporting system for wildlife sickened and killed by pesticides
Comments from Center for Food Safety on the EPA's Preliminary Pollinator Assessment to Support the Registration Review of Imidacloprid (EPA-HQ-OPP-2008-0844)
CFS comments on the Office of Science and Technology Policy's notice and request for information on Clarifying Current Roles and Responsibilities Described in the Coordinated Framework for the Regulation of Biotechnology